Detection of Helicopacter Pylori in Patients With Metabolic Associated Fatty Liver Disease
NCT07128147 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2026-01-13
Summary
Owing to the correlation between H.pylori and MAFLD, our study aims to search for H.pylori in every patient with MAFLD to aid in the management of MAFLD and improve quality of life for these patients by decreaseing morbidity and mortality.
Conditions
- Helicobacter Pylori Infection Metabolic Dysfunction-Associated Fatty Liver Disease
Sponsors & Collaborators
-
Assiut University
lead OTHER
Principal Investigators
-
Amira M Assiut University, Lecturer, MD, Trop Med · Assiut University
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-09-01
- Primary Completion
- 2026-09-01
- Completion
- 2027-09-01
More Related Trials
-
Evaluation of Patients With Liver Disease
NCT00001971 ·Status: RECRUITING
-
Spectrum, Profile and Outcome of Infections in Patients With Cirrhosis and/ or Acute on Chronic Liver Failure
NCT01872767 ·Status: COMPLETED
-
Macrophage-mediated Inflammation in White Adipose Tissue and Non-alcoholic Fatty Liver Disease.
NCT04059068 ·Status: COMPLETED
-
Role of Early API in Accurately Differentiating Hepatocellular Carcinoma From Dysplastic Nodules in Cirrhotic Patients
NCT07080372 ·Status: ACTIVE_NOT_RECRUITING
-
Screening for Metabolic Dysfunction Associated Fatty Liver Disease (MAFLD) at Al-Rajhy Hospital Nutrition Clinic. Assiut, Egypt
NCT04861012 ·Status: UNKNOWN ·Phase: NA
-
Fatty Liver and Ectopic Fat in Overweight and Obese Patients
NCT00886301 ·Status: COMPLETED ·Phase: NA
-
Non-invasive Evaluation of Hepatic Fibrosis in Patients With the Metabolic Syndrome
NCT00399932 ·Status: UNKNOWN
-
Identification of Microbial Properties Predicting a Worsening Course of Fatty Liver Disease
NCT03748511 ·Status: TERMINATED
-
Risk Factors for Hepatic Inflammation, Fibrosis and Prognosis in Patients With CHB and NAFLD
NCT05766449 ·Status: RECRUITING
-
Prevalence of Non-Alcoholic Fatty Liver Disease in Inflammatory Bowel Disease Patients
NCT06814600 ·Status: RECRUITING
-
Non-invasive Diagnostic Model of Liver Fibrosis Associated With NAFLD and Prediction of Prognosis
NCT03842748 ·Status: UNKNOWN
-
Cost Effective Non Invasive Diagnostic Modalities and Predictive Model for Development and Progression of Fibrosis Among Patients With Hepatitis B, Hepatitis C Infection or Non Alcoholic Fatty Liver Disease
NCT02658786 ·Status: WITHDRAWN
-
A Validation Cohort for ACLF Diagnosis and Prognosis
NCT03641872 ·Status: COMPLETED
-
Follow-up of Chronic Hepatitis B Patients With Comorbid Nonalcoholic Fatty Liver Disease
NCT02863757 ·Status: RECRUITING
-
The European NAFLD Registry
NCT04442334 ·Status: RECRUITING
-
Validity and Cost-Effectiveness of a New Screening Test for Hepatocellular Carcinoma
NCT00912847 ·Status: COMPLETED
-
Impact of FMT on the Phenome in Patients With NAFLD and Fibrosis
NCT06024681 ·Status: COMPLETED ·Phase: NA
-
Correlation Between Hepatic Fibrosis and Cardiovascular Risk Evaluated by Non-invasive Tests in Patients With NAFLD
NCT04774302 ·Status: COMPLETED
-
NASH: Non-invasive Diagnostic Markers and Imaging
NCT02717000 ·Status: UNKNOWN
-
Accuracy of Imaging Techniques in Diagnosing Steatohepatitis and Fibrosis in NAFLD Patients
NCT04785937 ·Status: RECRUITING ·Phase: NA
-
Quantification of Hepatic Fibrosis by IVIM Sequences in 1.5T MRI
NCT03173287 ·Status: UNKNOWN ·Phase: NA
-
Prediction of Significant Hepatic Fibrosis in HCV Carriers With PNALT by SAPI- A Validation Study
NCT00466271 ·Status: COMPLETED
-
Early Detection of Advanced Fatty Liver Disease
NCT03608748 ·Status: COMPLETED
-
Characteristics and Risk Factors for Invasive Fungal Infection With Acute-on-chronic Hepatitis B Liver Failure
NCT06190002 ·Status: NOT_YET_RECRUITING
-
Clinical Features and Natural History of Acute-on-Chronic Liver Failure in Korean Patients With Chronic Liver Disease
NCT02650011 ·Status: SUSPENDED